Zhejiang Xinguang Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 246.27 million compared to CNY 212.58 million a year ago. Revenue was CNY 246.27 million compared to CNY 212.58 million a year ago. Net income was CNY 87.98 million compared to CNY 75.22 million a year ago. Basic earnings per share from continuing operations was CNY 0.55 compared to CNY 0.47 a year ago. Diluted earnings per share from continuing operations was CNY 0.55 compared to CNY 0.47 a year ago.